Scarica l'app Stockscreener
67.59
0.07%
-0.05
Pre-mercato:
67.66
0.07
+0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$67.64
Aprire:
$68
Volume 24 ore:
305.87K
Relative Volume:
0.48
Capitalizzazione di mercato:
$2.58B
Reddito:
-
Utile/perdita netta:
$-212.18M
Rapporto P/E:
-11.28
EPS:
-5.9897
Flusso di cassa netto:
$-181.33M
1 W Prestazione:
+0.49%
1M Prestazione:
+3.70%
6M Prestazione:
-23.46%
1 anno Prestazione:
+39.07%
Intervallo 1D:
$66.70
$69.31
Intervallo di 1 settimana:
$64.98
$69.45
Portata 52W:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
67.59 | 2.58B | 0 | -212.18M | -181.33M | -5.9897 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss - marketscreener.com
Disc Medicine (NASDAQ: IRON) posts wider Q1 loss but holds $730M cash - Stock Titan
Disc Medicine 1Q 2026: Net income $(63.5M), EPS $(1.65) — 10-Q Summary - TradingView
IRON: Phase 3 bitopertin trial enrollment completed; strong cash position supports pipeline into 2029 - TradingView
Disc Medicine finishes Phase 3 rare-disease trial, eyes Q4 data - Stock Titan
IRON: Net loss widened to $63.5M in Q1 2026 as bitopertin's FDA review was delayed for more data - TradingView
Disc Medicine (NASDAQ: IRON) posts Q1 2026 loss and advances late-stage trials - Stock Titan
How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation - simplywall.st
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Caledonian Record
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Avoiding Lag: Real-Time Signals in (IRON) Movement - Stock Traders Daily
Disc Medicine, Inc. $IRON Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Jennison Associates LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - PR Newswire
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - Morningstar
Pictet Asset Management Holding SA Grows Stock Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Projected to Post Earnings on Thursday - MarketBeat
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
[ARS] Disc Medicine, Inc. SEC Filing - Stock Titan
Disc Medicine (NASDAQ: IRON) details 2026 proxy, pay and board votes - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers - MSN
Disc Medicine plunges on FDA complete response letter for bitopertin - MSN
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative? - Sahm
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Scott Coop
IRON Price Today: Disc Medicine, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch - TipRanks
Disc Medicine to present myelofibrosis trial data at ASCO meeting By Investing.com - Investing.com India
Discipline and Rules-Based Execution in IRON Response - Stock Traders Daily
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge - Yahoo Finance
Disc Medicine to present myelofibrosis trial data at ASCO meeting - Investing.com
Disc Medicine, Inc. to Present RALLY-MF Trial Data on DISC-0974 at ASCO Annual Meeting 2026 - Quiver Quantitative
Disc Medicine announced that the Phase 2 clinical trial data of its drug DISC-0974 in patients with myelofibrosis-associated anemia (RALLY-MF) have been selected for an oral presentation at the annual meeting of the American Society of Clinical Oncology. - Bitget
Myelofibrosis anemia data lands ASCO oral presentation on June 2 - Stock Titan
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - TMX Newsfile
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Rises By 21.4% - MarketBeat
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Franchi Jean M. | Chief Financial Officer |
Apr 14 '26 |
Sale |
69.24 |
6,257 |
433,234 |
64,333 |
| Franchi Jean M. | Chief Financial Officer |
Apr 13 '26 |
Sale |
69.00 |
400 |
27,600 |
70,590 |
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):